Thursday, January 4, 2024

EarlyDiagnostics Adds Co-CEO

Los Angeles-based EarlyDiagnostics announced this morning that it has appointed a new, Co-CEO to the company. According to the developer of cancer detection technology, it has appointed Gregory Critchfield as Co-CEO, effective January 1st. The company said Critchfield will work closely with co-founder and Co-CEO Xianghong Jasmine Zhou. Critchfield was a board member, former chairman and CEO, of Sera Prognostics, which he took from very early financing to an IPO in 2021. He also previously was at Myriad Genetic Laboratories and Quest Diagnostics.